NewsBite

Sirtex Medical receives $1.9b counter-bid from CDH Investments

Jonathan Shapiro
Jonathan ShapiroSenior reporter
Updated
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Biotech company Sirtex Medical has received $1.9 billion counter takeover offer from CDH Investments, a $US20 billion Chinese based alternative asset manager

The company was subject to a surprise $1.6 billion bid from New York listed Varian Medical and was placed in a trading halt on Friday morning pending the announcement of a "material development."

Loading...
Jonathan Shapiro writes about banking and finance, specialising in hedge funds, corporate debt, private equity and investment banking. He is based in Sydney. Connect with Jonathan on Twitter. Email Jonathan at jonathan.shapiro@afr.com
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

License article

Read More

Latest In Healthcare & fitness

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/business/health/sirtex-medical-receives-19b-counterbid-from-cdh-investments-20180504-h0znj7